Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RLMD compared with DRUG: revenue, margins and what each company keeps, and the suppliers and customers both name
RLMD
Relmada Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
DRUG
Bright Minds Biosciences Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
RLMD
Relmada Therapeutics, Inc.
vs
DRUG
Bright Minds Biosciences Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
RLMD: latest quarter not drawable. DRUG: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only RLMD
0
None
Shared
0
No disclosed counterparties: RLMD.
Only DRUG
11
—
Gerep Realty
unlisted
supplier
—
Technology Innovation Center
unlisted
supplier
—
ZoE Life Fulton Labs Incubator
unlisted
supplier
—
Dr. Cunningham lab
unlisted
supplier
7 more · DRUG chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
RLMD, solid
DRUG, dashed
RLMD
Relmada Therapeutics, Inc.
Change
4.24
▲
+10.33%
· post 4.33
· delayed
Mkt cap
$479.8M
DRUG
Bright Minds Biosciences Inc.
Change
21.49
▼
−17.99%
· post 21.20
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$200.1M
vs
Compare
After hours
Nov 3 '26
delayed
RLMD
Relmada Therapeutics, Inc.
vs
DRUG
Bright Minds Biosciences Inc.
4.24
▲
+10.33%
post 4.33
delayed
Price
21.49
▼
−17.99%
post 21.20
delayed
$479.8M
Mkt cap
$200.1M
Change
Change
RLMD
4.24
▲
+10.33%
vs
DRUG
21.49
▼
−17.99%
After hours
Nov 3 '26
delayed